Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
A resting heart rate under 60 beats per minute is common and often harmless while taking metoprolol, but a rate below 50, or any reading accompanied by dizziness, near-fainting, unusual fatigue, shortness of breath, chest pain, or confusion, is generally considered too low and should prompt a call to your prescriber, while a rate under 40 or actual fainting warrants emergency care. Your personal safe threshold depends on your dose, other medications, age, kidney and thyroid function, and whether you have conduction problems such as heart block or sinus node disease, so there are several important factors to weigh below before you ever consider skipping a dose. Never stop metoprolol abruptly, because sudden withdrawal can cause reb
Metoprolol is a beta-blocker commonly prescribed to treat high blood pressure, chest pain (angina), heart rhythm problems and to improve survival after a heart attack. One of its main effects is slowing down your heart rate (pulse). While a lower heart rate can be beneficial in many cardiovascular conditions, it’s important to know when it drops too far.
This guide will help you:
Always remember: if you experience anything life-threatening or serious, speak to a doctor right away.
Metoprolol blocks beta-1 receptors in the heart. This:
For many patients, a resting heart rate around 60–70 beats per minute (bpm) is both effective and safe. But beta-blockers can push that number lower—sometimes into the 40s.
“Bradycardia” simply means a slower than normal rate. In well-trained athletes, a resting rate in the 40s may be normal. But for most people on metoprolol, a rate consistently under 50-something warrants attention.
There’s no single cutoff that fits everyone. Your ideal heart rate depends on your age, fitness, medical history and other medications. However, general guidelines include:
If you’re asymptomatic and your doctor intentionally targeted a low heart rate (for example, in certain arrhythmias), rates in the 50s may be acceptable. But anything approaching the 40s—especially with symptoms—deserves prompt attention.
Even if your pulse is in the “acceptable” range on paper, symptoms can tip the balance. Watch for:
If any of these occur alongside a slow pulse, your heart may not be pumping enough blood to meet your body’s needs.
Managing these risks means balancing the benefits of rate control with the dangers of excessive slowing.
Regular monitoring helps you and your doctor find the right dose:
If you have a home blood pressure monitor with pulse reading, use that too—but confirm with manual checks occasionally.
Reach out if you notice:
Your doctor may suggest:
If you experience severe symptoms—such as chest pain, severe dizziness, fainting or confusion—treat this as an emergency:
For less urgent concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide your next steps.
Metoprolol offers proven benefits in:
But like any medication, it requires careful dose titration. Too much can slow your heart excessively; too little may not control your condition.
Key points:
Discuss any new exercise plans with your healthcare provider—especially if your heart rate is near the lower end of normal.
Your doctor may order:
Metoprolol is a valuable tool for managing heart conditions, but it requires respect and monitoring. A heart rate that’s too low can lead to dizziness, fatigue or even more serious complications. By keeping an eye on your pulse, noting how you feel and staying in close touch with your healthcare team, you can enjoy the benefits of metoprolol without undue risk.
If you ever wonder whether your heart rate is too low—or you notice worrying symptoms—be proactive:
Your health and safety come first. Always follow your prescribing physician’s advice and reach out whenever in doubt.
(References)
* Ahuja RC, Sinha N, Saran RK, Jain AK, Hasan M. Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study. Int J Cardiol. 1989 Dec;25(3):325-31. doi: 10.1016/0167-5273(89)90223-4. PMID: 2613380.
* Scheinman MM, Hess DS. New antiarrhythmic drugs. Am J Surg. 1983 Jun;145(6):724-32. doi: 10.1016/0002-9610(83)90129-0. PMID: 6407348.
* Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol. 1996 Feb 1;77(4):242-6. doi: 10.1016/s0002-9149(97)89386-1. PMID: 8607401.
* Rolfo F, Bobbio M, Angeli F, Cavallini C. [The POISE study]. G Ital Cardiol (Rome). 2008 Dec;9(12):803-7. PMID: 19119689.
* Raju VM, Gosling OE, Morgan-Hughes G, Colliver RJ, Iyengar S, Dissanayake P, Roobottom CA. High-dose intravenous metoprolol usage for reducing heart rate at CT coronary angiography: efficacy and safety. Clin Radiol. 2014 Jul;69(7):739-44. doi: 10.1016/j.crad.2014.03.003. Epub 2014 May 10. PMID: 24824980.
* Bebawi E, Jouni SS, Tessier AA, Frenette AJ, Brindamour D, Doré M. A metoprolol-terbinafine combination induced bradycardia. Eur J Drug Metab Pharmacokinet. 2015 Sep;40(3):295-9. doi: 10.1007/s13318-014-0205-x. Epub 2014 Jun 4. PMID: 24894748.
* Jiang J, Cong H, Zhang Y, Li Z, Tao G, Li X, Qing L, Tan N, Zhao Z, Dong Y, Ji Z, Chen Y, Ge J, He B, Sun Y, Cao K, Huo Y. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy. Int J Med Sci. 2017;14(5):477-483. doi: 10.7150/ijms.18054. Epub 2017 Apr 9. PMID: 28539824; PMCID: PMC5441040.
* Wang S, Zou R, Cai H, Wang Y, Ding Y, Tan C, Yang M, Li F, Wang C. Heart Rate and Heart Rate Difference Predicted the Efficacy of Metoprolol on Postural Tachycardia Syndrome in Children and Adolescents. J Pediatr. 2020 Sep;224:110-114. doi: 10.1016/j.jpeds.2020.05.017. Epub 2020 May 25. PMID: 32464225.
* Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. Clin Res Cardiol. 2022 Feb;111(2):141-153. doi: 10.1007/s00392-020-01692-z. Epub 2020 Jun 22. PMID: 32572551; PMCID: PMC8816306.
* Nunes MO, Witt DR, Casey SA, Stanberry LI, Caye DJ, J Chu B, Lindberg BJ, Lesser JR, Han BK. Safety, Efficacy, and Dose Protocol of Metoprolol for Heart Rate Reduction in Pediatric Outpatients Undergoing Cardiac CT Angiography. Arq Bras Cardiol. 2021 Jan;116(1):100-105. doi: 10.36660/abc.20190892. PMID: 33566972; PMCID: PMC8159495.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.